William Heflin Barton Iii, MD - Medicare Emergency Medicine in Tuscaloosa, AL

William Heflin Barton Iii, MD is a medicare enrolled "Emergency Medicine" physician in Tuscaloosa, Alabama. His current practice location is 1718 Veterans Memorial Parkway, Tuscaloosa, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 507-1100.

William Heflin Barton Iii is licensed to practice in Alabama (license number 29247) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1346408291.

Contact Information

William Heflin Barton Iii, MD
1718 Veterans Memorial Parkway,
Tuscaloosa, AL 35404
(205) 507-1100
Not Available



Physician's Profile

Full NameWilliam Heflin Barton Iii
GenderMale
SpecialityEmergency Medicine
Location1718 Veterans Memorial Parkway, Tuscaloosa, Alabama
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1346408291
  • Provider Enumeration Date: 05/28/2008
  • Last Update Date: 04/11/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 5597819045
  • Enrollment ID: I20090818000291

Medical Identifiers

Medical identifiers for William Heflin Barton Iii such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346408291NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 29247 (Alabama)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. William Heflin Barton Iii allows following entities to bill medicare on his behalf.
Entity NameParagon Contracting Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1225071459
PECOS PAC ID: 3971417825
Enrollment ID: O20050218000756

News Archive

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

VolitionRx announces additional colorectal cancer data at International Conference of Anticancer Research

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, today announced that further data analysis from its colorectal cancer study was presented today at the 9th International Conference of Anticancer Research, being held October 6-10, 2014 in Sithonia, Greece.

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

Study: Borna disease virus does not contain exact copies of genomic RNAs

Like bacteria, viruses have their own genome. The ends or termini of a viral RNA are especially interesting for virologists because they play an important role in reproduction and in the reaction of the innate immune system to the virus.

Read more Medical News

› Verified 3 days ago

Entity NameRelias Emergency Medicine Specialists Of Fayette Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093201543
PECOS PAC ID: 6800147604
Enrollment ID: O20180918001531

News Archive

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

VolitionRx announces additional colorectal cancer data at International Conference of Anticancer Research

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, today announced that further data analysis from its colorectal cancer study was presented today at the 9th International Conference of Anticancer Research, being held October 6-10, 2014 in Sithonia, Greece.

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

Study: Borna disease virus does not contain exact copies of genomic RNAs

Like bacteria, viruses have their own genome. The ends or termini of a viral RNA are especially interesting for virologists because they play an important role in reproduction and in the reaction of the innate immune system to the virus.

Read more Medical News

› Verified 3 days ago

Entity NameRelias Emergency Medicine Specialists Of Northport, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699261149
PECOS PAC ID: 2668724634
Enrollment ID: O20181003001104

News Archive

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

VolitionRx announces additional colorectal cancer data at International Conference of Anticancer Research

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, today announced that further data analysis from its colorectal cancer study was presented today at the 9th International Conference of Anticancer Research, being held October 6-10, 2014 in Sithonia, Greece.

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

Study: Borna disease virus does not contain exact copies of genomic RNAs

Like bacteria, viruses have their own genome. The ends or termini of a viral RNA are especially interesting for virologists because they play an important role in reproduction and in the reaction of the innate immune system to the virus.

Read more Medical News

› Verified 3 days ago

Entity NameRelias Emergency Medicine Specialists Of Regional, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619463163
PECOS PAC ID: 9436401106
Enrollment ID: O20181008000902

News Archive

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

VolitionRx announces additional colorectal cancer data at International Conference of Anticancer Research

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, today announced that further data analysis from its colorectal cancer study was presented today at the 9th International Conference of Anticancer Research, being held October 6-10, 2014 in Sithonia, Greece.

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

Study: Borna disease virus does not contain exact copies of genomic RNAs

Like bacteria, viruses have their own genome. The ends or termini of a viral RNA are especially interesting for virologists because they play an important role in reproduction and in the reaction of the innate immune system to the virus.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William Heflin Barton Iii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
William Heflin Barton Iii, MD
619 19th St S,
Birmingham, AL 35249-1900

Ph: () -
William Heflin Barton Iii, MD
1718 Veterans Memorial Parkway,
Tuscaloosa, AL 35404

Ph: (205) 507-1100

News Archive

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

VolitionRx announces additional colorectal cancer data at International Conference of Anticancer Research

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, today announced that further data analysis from its colorectal cancer study was presented today at the 9th International Conference of Anticancer Research, being held October 6-10, 2014 in Sithonia, Greece.

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

Study: Borna disease virus does not contain exact copies of genomic RNAs

Like bacteria, viruses have their own genome. The ends or termini of a viral RNA are especially interesting for virologists because they play an important role in reproduction and in the reaction of the innate immune system to the virus.

Read more News

› Verified 3 days ago


Emergency Medicine Doctors in Tuscaloosa, AL

Nicholas Machael Vetrano, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401
Phone: 205-759-7122    
Dr. Alan Heins, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 750 5th Ave E, Tuscaloosa, AL 35401
Phone: 205-348-6262    Fax: 205-348-6262
Nicholas Charles Ruth,
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 850 Peter Bryce Blvd, Tuscaloosa, AL 35401
Phone: 205-348-1770    Fax: 205-348-1772
Dr. Phillip Kelley Bobo, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 32 15th St, Tuscaloosa, AL 35401
Phone: 205-345-2326    Fax: 205-345-0708
Christopher Earl Mcgee, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 5005 Oscar Baxter Dr, Tuscaloosa, AL 35405
Phone: 205-343-2225    
Dr. Jf Donal Conway, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401
Phone: 205-759-7122    
Jeremey Lindley, DO
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401
Phone: 205-759-7111    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.